Hank A. Plain , BS

Partner

Morgenthaler Ventures
Menlo Park, CA

Hank A. Plain joined Morgenthaler Ventures as a Partner in 2007 after more than 25 years in the life science industry, including co-founding eight medical device start-ups and directing the exits of six companies with a combined value well in excess of $3 billion. Morgenthaler Ventures has funded companies such as Apple and Ardian. He is based in Menlo Park, California and is focused on medical device investments. In November 2010 Medtronic announced the acquisition of Ardian for $800 million upfront, plus uncapped annual revenue growth milestones through Medtronic's fiscal 2015. Mr. Plain is a founder, helped incubate Ardian at The Foundry and served as a director of the company. He was a board member on the deal committee that helped to successfully negotiate the January 2010 acquisition of Acclarent by Johnson & Johnson for $785 million. Mr. Plain is the Vice Chairman of The Foundry, where he co-founded Ardian, Cabochon, ForSight Labs, ForSight Vision2, Miramar, Satiety and Transcend. He also served as President and CEO of Perclose from 1993 to 2000, during which he led the company to $100 million in sales and managed the company's successful IPO and acquisition in 1999 by Abbott Laboratories. He was Chairman of Embolic Protection, where he helped negotiate the acquisition of the company in 2001 by Boston Scientific. He also served as a Director at TransVascular until Medtronic acquired the company in 2003. Previously, Mr. Plain worked at Eli Lilly for 12 years in various management positions. Mr. Plain holds a B.S. in Finance from University of Missouri-Columbia. Additionally, he sits on the boards of Access Closure, Ardian, Cabochon Aesthetics, Innovative Pulmonary Solutions, Kona Medical, Miramar, Moximed, and The Foundry.